首页> European journal of immunology> Adapted Live SARS-CoV-2 Vaccine Elicits Rapid Mucosal Immunity, Protects From Disease, and Reduces Shedding of XBB.1.5.

Adapted Live SARS-CoV-2 Vaccine Elicits Rapid Mucosal Immunity, Protects From Disease, and Reduces Shedding of XBB.1.5.

导出 OA

翻译打印收藏纠错

第一作者： Jana,Kochmann

第一单位： Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

作者： Jana,Kochmann ^[1] ; Tobias,Britzke ^[2] ; Nico Joël,Halwe ^[3] ; Lorenz,Ulrich ^[3] ; Angele,Breithaupt ^[2] ; G Tuba,Barut ^[4] ; Nadine,Ebert ^[4] ; Bettina Salome,Trüeb ^[4] ; Volker,Thiel ^[5] ; Anca,Dorhoi ^[1] ; Martin,Beer ^[3] ; Donata,Hoffmann ^[3] ; Björn,Corleis ^[1] ; Jacob,Schön ^[3]

作者单位： Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. ^[1] Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. ^[2] Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. ^[3] Institute of Virology and Immunology, Bern and Mittelhäusern, Bern, Switzerland.;Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. ^[4] Institute of Virology and Immunology, Bern and Mittelhäusern, Bern, Switzerland.;Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.;Multidisciplinary Center for Infectious Diseases, University of Bern, Bern, Switzerland.;European Virus Bioinformatics Center, Jena, Germany. ^[5]